Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Health Catalyst, Inc.    HCAT

HEALTH CATALYST, INC.

(HCAT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Catalyst Announces Agreement to Acquire Vitalware, a Revenue Workflow Optimization and Analytics SaaS Technology Solution

08/11/2020 | 04:10pm EST

SALT LAKE CITY, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that it has entered into a definitive agreement to acquire Vitalware, LLC, a Yakima, Washington-based provider of revenue workflow optimization and analytics SaaS technology solutions to healthcare organizations.

Vitalware’s flagship offering is a Best in KLAS chargemaster management solution that delivers results for the complex regulatory and compliance functions needed by all healthcare provider systems. Additionally, Vitalware brings to bear newer product suites in Revenue Integrity, to help health systems capture lost revenue, and Price Transparency, to support compliance with expanding pricing transparency regulation. Importantly, Vitalware offers Health Catalyst a strategic anchor technology in the revenue space, expanding its CFO offering and value proposition. Vitalware’s solutions support all major EMRs and act as a key integration point for health systems with multiple EMRs.

Health Catalyst CEO Dan Burton said, “We are excited to welcome the Vitalware team to support our shared mission to be the catalyst for massive, measurable improvements. In addition to adding a best in KLAS technology solution from Vitalware, this acquisition is another powerful example of Health Catalyst’s ability to integrate and scale software on top of our DOS™ platform. Ultimately, DOS, our cloud-based data platform, will further enhance the analytics insights made available by Vitalware’s technology by integrating charge and revenue data with claims, cost, and quality data.”

“Vitalware, since inception, has been about delivering solutions that provide critical insights and better financial outcomes to health systems,” said Vitalware CEO and Co-founder, Kerry Martin. “We have a great team committed to our clients and their success, and adding the expertise and solutions from the Health Catalyst team will allow Vitalware to deliver even more innovative solutions. Our number one priority continues to be to create positive outcomes for our clients, and we’re confident the combination of our resources with Health Catalyst will only accelerate that effort.”

Health Catalyst expects to fund the transaction using a mix of stock and cash. The parties expect the transaction, which is subject to customary closing conditions, to close in the third or fourth quarter of 2020. Further details regarding the acquisition will be reported on a Form 8-K filing that will be filed with the Securities and Exchange Commission today.

About Health Catalyst
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations, and is committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

About Vitalware
Vitalware is the leading mid-cycle revenue SaaS solutions provider, specializing in Health-IT applications aimed at making the business of healthcare easier through its intuitive cloud-based technologies and regulatory content expertise. With nearly 1,000 hospitals on its client roster, Vitalware’s product portfolio is the healthcare industry’s best solution for providing visibility and continuity in chargemaster management, pricing transparency, charge capture, and regulatory code references. Beyond providing tools, and healthcare regulatory and compliance resources, Vitalware offers professional services designed to support organizations’ need of coding guidance, process improvement, education, and financial impact solutions. Vitalware is recognized as a 2020 Best in KLAS software for its VitalCDM® platform. Visit our website, www.vitalware.com.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements relating to expectations, plans, and prospects including expectations relating to our ability to close, and the timing of the closing of, this transaction and the benefits that will be derived from this transaction. These forward-looking statements are based upon the current expectations and beliefs of Health Catalyst’s management as of the date of this release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements including, without limitation, the risk of adverse and unpredictable macro-economic conditions and risks related to closing this transaction and integration of the companies. All forward-looking statements in this press release are based on information available to the Company as of the date hereof, and Health Catalyst disclaims any obligation to update these forward-looking statements.

Health Catalyst Investor Relations Contact:
Adam Brown
Senior Vice President, Investor Relations
+1 (855)-309-6800
ir@healthcatalyst.com

Health Catalyst Media Contact:
Kristen Berry
Senior Vice President, Public Relations
+1 (617) 234-4123
+1 (774) 573-0455 (m)
kberry@we-worldwide.com

Primary Logo


© GlobeNewswire 2020
All news about HEALTH CATALYST, INC.
02/26HEALTH CATALYST : Raymond James Adjusts Price Target on Health Catalyst to $56 F..
MT
02/26HEALTH CATALYST : RBC Capital Adjusts Health Catalyst's Price Target to $52 From..
MT
02/26Health Catalyst to Participate in Upcoming Investor Conferences
GL
02/25HEALTH CATALYST : 4Q Earnings Snapshot
AQ
02/25HEALTH CATALYST : Management's Discussion and Analysis of Financial Condition an..
AQ
02/25HEALTH CATALYST, INC. : Results of Operations and Financial Condition, Financial..
AQ
02/25HEALTH CATALYST : Earnings Flash (HCAT) HEALTH CATALYST Posts Q4 EPS $-0.16, vs...
MT
02/25HEALTH CATALYST : Earnings Flash (HCAT) HEALTH CATALYST Reports Q4 Revenue $53.3..
MT
02/25Health Catalyst Reports Fourth Quarter and Year End 2020 Results
GL
02/25HEALTH CATALYST : Healthcare Analytics Market Share, Size, Value, Trends, Demand..
AQ
More news
Financials (USD)
Sales 2021 227 M - -
Net income 2021 -88,5 M - -
Net cash 2021 74,9 M - -
P/E ratio 2021 -23,0x
Yield 2021 -
Capitalization 2 136 M 2 136 M -
EV / Sales 2021 9,06x
EV / Sales 2022 7,59x
Nbr of Employees 1 000
Free-Float 91,8%
Chart HEALTH CATALYST, INC.
Duration : Period :
Health Catalyst, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HEALTH CATALYST, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Average target price 53,46 $
Last Close Price 48,49 $
Spread / Highest target 23,7%
Spread / Average Target 10,3%
Spread / Lowest Target -9,26%
EPS Revisions
Managers and Directors
NameTitle
Daniel D. Burton Chief Executive Officer & Director
Patrick J. Nelli President
Bryan Hunt Chief Financial Officer
Holly Rimmasch Chief Clinical Officer
Bryan Hinton Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
HEALTH CATALYST, INC.11.39%2 136
THERMO FISHER SCIENTIFIC-3.37%177 239
DANAHER CORPORATION-1.11%156 450
INTUITIVE SURGICAL, INC.-9.94%86 735
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.-1.88%78 503
ILLUMINA, INC.18.76%64 110